News Quantified

MRNS – marinus pharmaceuticals, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

-12.4%

BEAT

-4.1%

MISS

-9.5%

IN-LINE

-2.3%

MISS

Cantor Fitzgerald

Cantor Fitzgerald

Form 8-K MARINUS PHARMACEUTICALS, For: Dec 17

Form 8-K MARINUS PHARMACEUTICALS, For: Dec 06

Form 144 MARINUS PHARMACEUTICALS, Filed by: Nochur Sara

Form SC 13G/A MARINUS PHARMACEUTICALS, Filed by: PRUDENTIAL FINANCIAL INC

Form 8-K MARINUS PHARMACEUTICALS, For: Nov 14

Top News Gainers

12/10 Form 424B5 MARINUS PHARMACEUTICALS 52.1%

12/19 Marinus Pharmaceuticals Inc (NASDAQ: MRNS) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $6.00 price target on the stock. 37.3%

3/19 Marinus Pharmaceuticals Appoints Sasha Damouni Ellis as Vice President, Investor Relations and Corporate Communications 37.3%

3/20 Marinus Pharmaceuticals Inc (NASDAQ: MRNS) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 36.4%

7/25 Marinus Pharmaceuticals Inc (NASDAQ: MRNS) had its "buy" rating re-affirmed by analysts at LADENBURG THALM/SH SH. They now have a $3.00 price target on the stock. 24.4%

3/16 Form 10-K MARINUS PHARMACEUTICALS For: Dec 31 21.0%

2/14 Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 16.4%

2/24 Marinus Pharmaceuticals to Participate at Three Upcoming Investor Healthcare Conferences 16.3%

3/23 MARINUS PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) 12.9%

9/26 Marinus Pharmaceuticals Announces Positive Top-Line Results With Ganaxolone in Phase 2 Refractory Status Epilepticus Trial 12.7%

Top News Decliners

7/23 Form 8-K MARINUS PHARMACEUTICALS For: Jul 23 -21.6%

3/16 Marinus Pharmaceuticals Provides Business Reports Update and 2019 Financial Results -20.7%

4/1 Marinus Pharmaceuticals Inc (NASDAQ: MRNS) had its "buy" rating re-affirmed by analysts at LADENBURG THALM/SH SH. They now have a $5.00 price target on the stock. -13.1%

9/26 Marinus up 58% premarket on positive ganaloxone data [Seeking Alpha] -11.5%

9/26 Marinus Pharmaceuticals Inc (NASDAQ: MRNS) had its "buy" rating re-affirmed by analysts at LADENBURG THALM/SH SH. They now have a $5.00 price target on the stock. -10.1%

10/17 Marinus Phase 2 Clinical Data on Ganaxolone in RSE Presented at Neurocritical Care Society Meeting -7.6%

11/18 Marinus Pharmaceuticals Inc (NASDAQ: MRNS) had its "buy" rating re-affirmed by analysts at LADENBURG THALM/SH SH. They now have a $5.00 price target on the stock. -7.6%

10/29 Marinus Pharmaceuticals Appoints Joe Hulihan, M.D., as Chief Medical Officer -7.5%

4/2 Form 8-K MARINUS PHARMACEUTICALS For: Mar 31 -7.5%

12/12 Form 424B5 MARINUS PHARMACEUTICALS -6.9%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day